Axonics Profit Margin

Axonics (AXNX) currently reports a profit margin of -1.31% as of September 2024. That compares with -4.4% in the prior-year period — up 70.2% year over year. That is below the Healthcare sector average of 14.34%. Use the charts on this page to explore Axonics's profit margin history and peer comparisons.

Axonics's profit margin increased from -4.4% to -1.31% — a 70.2% year-over-year increase (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Axonics's profit margin of -1.31% is lower than the Healthcare sector average of 14.34%. That is roughly 109.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Axonics's current -1.31% should be judged against Healthcare norms (sector average: 14.34%) and against AXNX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -1.31%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 14.34%. From there, open related valuation or income-statement pages for Axonics, and consider following AXNX for alerts when major investors trade the stock.